We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Daniel Di Luca MD

Daniel G. Di Luca MD

Clinical Fellow, Edmond J. Safra Program in Parkinson's Disease, Movement Disorders Clinic, Krembil Brain Institute, Toronto Western Hospital, Toronto, Ontario, Canada

Daniel Garbin Di Luca is a movement disorders fellow at the Toronto Western Hospital, University of Toronto. He completed his Neurology residency at the University of Miami, where he also served as a chief resident and was elected into the Alpha Omega Alpha (AOA) Honor Medical Society. During his medical training, he also received grant funding to perform a research fellowship at Massachusetts General Hospital/Harvard Medical School to investigate the role of caffeine and adenosine in Parkinson’s Disease. His main research interests include neuromodulation, epidemiology, and novel therapies for motor and non-motor symptoms in Parkinson’s Disease and other movement disorders.


Dr. Di Luca is partially supported from funds from Porridge for Parkinson’s and has also received additional stipend from the International Parkinson and Movement Disorder Society.